Indeed, microglia lacking TREM2 expression exhibit greatly diminished activation against disease pathology, correlating with increased risk of Alzheimer’s disease (AD) (Krasemann et al., 2017; McQuade et al., 2020; Cheng et al., 2018). This evidence concerns the gene TREM2 and Alzheimer disease.